MAZE vs. CCJ
MAZE (Maze Therapeutics, Inc) and CCJ (Cameco Corporation) are both stocks. MAZE operates in Biotechnology (Healthcare), while CCJ operates in Uranium (Energy). Over the past year, MAZE returned 77.49% vs 52.94% for CCJ. At a 0.18 correlation, their price movements are largely independent.
Performance
MAZE vs. CCJ - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MAZE achieves a -41.95% return, which is significantly lower than CCJ's 10.35% return.
MAZE
- 1D
- -0.17%
- 1M
- -10.79%
- YTD
- -41.95%
- 6M
- -38.11%
- 1Y
- 77.49%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
CCJ
- 1D
- 2.01%
- 1M
- -12.51%
- YTD
- 10.35%
- 6M
- 10.35%
- 1Y
- 52.94%
- 3Y*
- 47.60%
- 5Y*
- 36.72%
- 10Y*
- 25.74%
MAZE vs. CCJ - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
MAZE Maze Therapeutics, Inc | -41.95% | 157.01% |
CCJ Cameco Corporation | 10.35% | 82.24% |
Correlation
The correlation between MAZE and CCJ is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.20 |
Correlation (All Time) Calculated using the full available price history since Jan 31, 2025 | 0.18 |
Fundamentals
MAZE:
$1.30B
CCJ:
$43.98B
MAZE:
-$2.63
CCJ:
CA$1.49
MAZE:
3.79
CCJ:
8.68
MAZE:
$0.00
CCJ:
CA$3.54B
MAZE:
-$1.15M
CCJ:
CA$1.04B
MAZE:
-$126.66M
CCJ:
CA$996.66M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MAZE vs. CCJ — Risk / Return Rank
MAZE
CCJ
MAZE vs. CCJ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Maze Therapeutics, Inc (MAZE) and Cameco Corporation (CCJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MAZE | CCJ | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.09 | ||
| Sortino ratioReturn per unit of downside risk | +0.21 | ||
| Omega ratioGain probability vs. loss probability | 1.27 | 1.20 | +0.07 |
| Calmar ratioReturn relative to maximum drawdown | 1.43 | 1.83 | -0.40 |
| Martin ratioReturn relative to average drawdown | 3.16 | 4.43 | -1.26 |
Loading charts...
Drawdowns
MAZE vs. CCJ - Drawdown Comparison
The maximum MAZE drawdown since its inception was -54.51%, smaller than the maximum CCJ drawdown of -87.53%. Use the drawdown chart below to compare losses from any high point for MAZE and CCJ.
Loading charts...
Drawdown Indicators
| MAZE | CCJ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -54.51% | -87.53% | +33.02% |
Max Drawdown (1Y)Largest decline over 1 year | -54.51% | -29.13% | -25.38% |
Max Drawdown (3Y)Largest decline over 3 years | — | -40.01% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -40.01% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -57.22% | — |
Current DrawdownCurrent decline from peak | -53.60% | -24.71% | -28.89% |
Average DrawdownAverage peak-to-trough decline | -20.99% | -46.07% | +25.08% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 24.60% | 11.99% | +12.61% |
Volatility
MAZE vs. CCJ - Volatility Comparison
The current volatility for Maze Therapeutics, Inc (MAZE) is 11.72%, while Cameco Corporation (CCJ) has a volatility of 17.90%. This indicates that MAZE experiences smaller price fluctuations and is considered to be less risky than CCJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MAZE | CCJ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.72% | 17.90% | -6.18% |
Volatility (6M)Calculated over the trailing 6-month period | 56.26% | 39.91% | +16.35% |
Volatility (1Y)Calculated over the trailing 1-year period | 89.54% | 55.17% | +34.37% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 94.20% | 50.01% | +44.19% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 94.20% | 46.75% | +47.45% |
Dividends
MAZE vs. CCJ - Dividend Comparison
MAZE has not paid dividends to shareholders, while CCJ's dividend yield for the trailing twelve months is around 0.17%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CCJ Cameco Corporation | 0.17% | 0.19% | 0.22% | 0.20% | 0.39% | 0.29% | 0.46% | 0.67% | 0.53% | 4.33% | 3.82% | 3.24% |
MAZE Maze Therapeutics, Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
MAZE vs. CCJ - Financials Comparison
This section allows you to compare key financial metrics between Maze Therapeutics, Inc and Cameco Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
MAZE and CCJ have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CCJ has higher volatility (17.90%) compared to MAZE (11.72%). In terms of maximum drawdown, MAZE dropped -54.51% vs CCJ's -87.53%.
CCJ currently has the higher Sharpe Ratio (0.96 vs 0.87), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MAZE and CCJ
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer